title: Cervical cytologic examination during physical checkup of pregnant women: cervical cancer screening in women under the age of thirty.
abstract: Recently, the Ministry of Health, Labor and Welfare proposed that cervical cancer screening should be conducted for women aged 20 to 29 years old in Japan. However, there are insufficient data available in Japan concerning the screening conducted for women under the age of 30. Therefore, we made a survey of the results of cervical cytologic examination for pregnant women. 28,616 pregnant women were examined as subjects of a study group. A group of 108,289 women, subjected to group screening for cervical cancer in Miyagi Prefecture, were studied as a control group. The rate of subjects who required close examination in the pregnant women's group was significantly higher than that in the mass screening group (1.12% vs. 0.84%). The rate of close examination was significantly higher in the women 19 years old or younger compared to those in the age group of 25 to 39 years old. The rate was also significantly higher in women aged 20 to 24 years old than those who are 25 to 34 years old. Of the 321 subjects who required close examination, 34 cases underwent treatment, and 17 cases were under age 30. Moreover, all three cases of microinvasive and/or invasive carcinoma were under the age of 30 years (23, 23, 27 years old, respectively). Our results suggest that screening for cervical cancer in pregnancy is a useful means to find cervical neoplasia in young women and is effective in reducing the cervical cancer morbidity rate.
authors.affiliation: Department of Obstetrics and Gynecology, Tohoku University, Sendai 980-8574, Japan.
authors.forename: Yoriko
authors.initials: Y
authors.lastname: Abe
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Ito
authors.forename: Chikako
authors.initials: C
authors.lastname: Okamura
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Niikura
authors.forename: Yukihiro
authors.initials: Y
authors.lastname: Terada
authors.forename: Takashi
authors.initials: T
authors.lastname: Murakami
authors.forename: Tadao
authors.initials: T
authors.lastname: Takano
authors.forename: Nobuyoshi
authors.initials: N
authors.lastname: Ozawa
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Nagai
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Wada
authors.forename: Shigeki
authors.initials: S
authors.lastname: Uehara
authors.forename: Takanori
authors.initials: T
authors.lastname: Watanabe
authors.forename: Shingo
authors.initials: S
authors.lastname: Tanigawara
authors.forename: Shigesato
authors.initials: S
authors.lastname: Wagatsuma
authors.forename: Yuji
authors.initials: Y
authors.lastname: Yoshida
authors.forename: Tsukasa
authors.initials: T
authors.lastname: Igarashi
authors.forename: Masakuni
authors.initials: M
authors.lastname: Suzuki
authors.forename: Kimio
authors.initials: K
authors.lastname: Nakagawa
authors.forename: Kunihiro
authors.initials: K
authors.lastname: Okamura
authors.forename: Nobuo
authors.initials: N
authors.lastname: Yaegashi
mesh_terms: D000328:Adult; D002584:Cervix Uteri / Q000166:cytology* / Q000473:pathology; D005260:Female; D006801:Humans; D007564:Japan; D008403:Mass Screening; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000175:diagnosis*; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control